Wave life sciences ltd. (WVE)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15
Revenue

17,118

15,983

17,203

18,767

16,018

14,414

11,892

8,714

4,932

3,893

3,187

2,289

0

-

0

0

-

152

0

0

0

Operating expenses:
Research and development

176,476

175,431

166,112

154,403

145,345

134,428

119,988

107,209

93,765

79,309

67,935

61,524

50,822

40,818

30,291

18,737

12,186

9,057

0

0

0

General and administrative

50,964

48,869

47,818

45,144

42,409

39,509

33,642

31,364

29,126

26,975

25,273

21,641

18,628

15,994

14,555

13,474

11,725

10,393

0

0

0

Total operating expenses

227,440

224,300

213,930

199,547

187,754

173,937

153,630

138,573

122,891

106,284

93,208

83,165

69,450

56,812

44,846

32,211

23,911

19,450

0

0

0

Loss from operations

-210,322

-208,317

-196,727

-180,780

-171,736

-159,523

-141,738

-129,859

-117,959

-102,391

-90,130

-81,010

-67,975

-55,720

-44,037

-31,794

-23,785

-19,298

0

0

0

Other income, net:
Dividend income

3,873

4,912

5,190

5,046

4,436

3,368

2,645

2,096

1,644

1,578

0

0

0

-

-

-

-

-

-

-

-

Interest income, net

21

29

31

30

26

22

17

13

10

6

14

131

236

337

353

220

0

-

0

0

-

Other income (expense), net

9,497

9,738

16,648

13,941

11,559

9,549

-504

-111

84

-331

-236

-197

-118

-50

-124

24

2

56

0

0

0

Total other income, net

13,391

14,679

21,869

19,017

16,021

12,939

2,158

1,998

1,738

1,253

1,320

961

663

542

280

335

192

142

0

0

0

Loss before income taxes

-196,931

-193,638

-174,858

-161,763

-155,715

-146,584

-139,580

-127,861

-116,221

-101,138

-88,810

-80,049

-67,312

-55,178

-43,757

-31,459

-23,593

-19,156

0

0

0

Income tax provision

0

0

-103

-103

-103

69

-21

-439

-96

842

1,090

1,892

1,597

482

289

-12

-11

44

0

0

0

Net loss

-196,931

-193,638

-174,755

-161,660

-155,612

-146,653

-139,559

-127,422

-116,125

-101,980

-89,900

-81,941

-68,909

-55,660

-44,046

-31,447

-23,582

-19,200

0

0

0

Net loss per share attributable to ordinary shareholders—basic and diluted

-1.38

-1.66

-1.48

-1.22

-1.36

-1.29

-1.28

-1.23

-1.26

-1.12

-0.92

-0.91

-0.90

-0.82

-0.75

-0.51

-0.36

-0.47

-0.54

-0.40

-0.42

Weighted-average ordinary shares used in computing net loss per share attributable to ordinary shareholders—basic and diluted

34,461

34,327

34,281

34,260

32,597

29,484

29,333

29,144

27,919

27,863

27,758

26,899

23,531

23,497

23,445

22,708

21,551

15,285

9,223

9,223

8,273

Other comprehensive income (loss):
Net loss

-196,931

-193,638

-174,755

-161,660

-155,612

-146,653

-134,260

0

0

-

0

-

-

-

-

-

-

-

-

-

-

Foreign currency translation

23

114

101

79

85

37

453

474

441

407

0

0

0

-

-

-

-

-

-

-

-

Comprehensive loss

-196,908

-193,524

-174,654

-161,581

-155,527

-146,616

-139,106

-126,948

-115,684

-101,573

0

0

0

-

-

-

-

-

-

-

-